Xpert at 8 years: where are we now, and what should we do next?

Editorial

D W Dowdy. Int J Tuberc Lung Dis. 2019.

. 2019 Jan 1;23(1):3-4.

doi: 10.5588/ijtld.18.0717.

No abstract available

Conflict of interest statement

Conflicts of interest: none declared.

Ensuring that Xpert^® MTB/RIF is used to its maximum potential.
Harries AD, Timire C, Takarinda KC, Sandy C. Harries AD, et al. Int J Tuberc Lung Dis. 2019 Sep 1;23(9):1043-1044. doi: 10.5588/ijtld.19.0082. Int J Tuberc Lung Dis. 2019. PMID: 31615615 Free PMC article. No abstract available.
Expand the RRDR hotspot to improve GeneXpert results.
Mishra B, Mohapatra PR. Mishra B, et al. Int J Tuberc Lung Dis. 2019 Sep 1;23(9):1043. doi: 10.5588/ijtld.19.0103. Int J Tuberc Lung Dis. 2019. PMID: 31657297 No abstract available.

Treatment outcomes, diagnostic and therapeutic impact: Xpert vs. smear. A systematic review and meta-analysis.
Agizew T, Boyd R, Auld AF, Payton L, Pals SL, Lekone P, Chihota V, Finlay A. Agizew T, et al. Int J Tuberc Lung Dis. 2019 Jan 1;23(1):82-92. doi: 10.5588/ijtld.18.0203. Int J Tuberc Lung Dis. 2019. PMID: 30674379 Free PMC article.

1. World Health Organization . WHO endorses new rapid tuberculosis test Geneva, Switzerland: WHO, 2010. http://www.who.int/mediacentre/news/releases/2010/tb_test_20101208/en/. Accessed December 2018.
1. World Health Organization. Xpert MTB/RIF assay for the diagnosis of TB: meeting report. WHO/HTM/TB/2016.19 Geneva, Switzerland: WHO, 2016. http://www.who.int/tb/laboratory/xpert_report_2016.pdf?ua=1. Accessed December 2018.
1. Agizew T, Boyd R, Auld A, et al. Treatment outcomes, diagnostic and therapeutic impact: Xpert versus smear systematic review and meta-analysis. Int J Tuberc Lung Dis 2019; 23: 82–92. - PMC - PubMed
1. Albert H, Nathavitharana RR, Isaacs C, Pai M, Denkinger CM, Boehme CC. Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better? Eur Respir J 2016; 48: 516–525. - PMC - PubMed
1. Ngwira LG, Corbett EL, Khundi M, et al. Screening for tuberculosis with Xpert MTB/RIF versus fluorescent microscopy among adults newly diagnosed with HIV in rural Malawi: a cluster randomized trial (CHEPETSA). Clin Infect Dis 2018. July 27 [Epub ahead of print] - PMC - PubMed